Tscan Therapeutics Inc
(TCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 169,506 | 169,394 | 154,108 | 178,689 | 133,118 |
| Marketable Securities | 14,947 | 48,651 | 97,581 | 111,421 | 138,002 |
| TOTAL | $188,165 | $221,130 | $254,836 | $292,722 | $274,085 |
| Non-Current Assets | |||||
| PPE Net | 9,303 | 9,521 | 8,351 | 7,242 | 7,461 |
| Investments And Advances | 288 | 1,782 | 1,755 | 1,766 | 1,807 |
| Other Non-Current Assets | 64,469 | 66,128 | 67,767 | 69,388 | 64,674 |
| TOTAL | $74,060 | $77,431 | $77,873 | $78,396 | $73,942 |
| Total Assets | $262,225 | $298,561 | $332,709 | $371,118 | $348,027 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,353 | 4,539 | 4,966 | 4,278 | 3,647 |
| Accrued Expenses | 10,765 | 12,797 | 9,607 | 15,410 | 11,181 |
| TOTAL | $29,208 | $31,322 | $29,816 | $35,956 | $28,660 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,414 | 32,296 | 32,182 | 32,072 | 30,647 |
| Deferred Revenues | 5,186 | 7,698 | 10,272 | 11,698 | 9,934 |
| Other Non-Current Liabilities | 56,582 | 58,229 | 60,008 | 60,874 | 55,957 |
| TOTAL | $88,996 | $90,525 | $92,691 | $94,192 | $90,280 |
| Total Liabilities | $118,204 | $121,847 | $122,507 | $130,148 | $118,940 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,748 | 56,748 | 56,591 | 56,591 | 53,371 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -481,885 | -446,175 | -409,223 | -375,096 | -339,287 |
| Other shareholders' equity | 2 | -4 | -4 | 51 | 0 |
| TOTAL | $144,021 | $176,714 | $210,202 | $240,970 | $229,087 |
| Total Liabilities And Equity | $262,225 | $298,561 | $332,709 | $371,118 | $348,027 |